Non-small cell lung cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Non-small cell lung cancer 2. Histopathological image, genetic test results, clinical information, and imaging information 3. Written informed consent in LC-SCRUM-IBIS regarding secondary use of remaining sample and information 4. No rejection against secondary use of remaining sample and information, whose information is provided in the form of opt-out on the web-site
Exclusion criteria
Exclusion criteria: 1. Patients whose participation in the trial is judged to be inappropriate by the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The performance of a detection evaluated by the area under the ROC curve, or AUC, for rare driver gene (ALK, ROS1, RET, BRAF, NTRK, MET, HER2, KRAS) | — |
Countries
Japan
Contacts
National Cancer Center Hospital East Department of Thoracic Medical Oncology